Tag: STAT+

February 24, 2026

Hims & Hers Earnings: GLP-1 Scrutiny & Weight Loss Future

February 23, 2026

Gilead to Acquire Arcellx for $7.8B in Cancer Therapy Deal

February 21, 2026

FDA Scrutiny of Antidepressants & RSV Shots, Antibiotic Production Shifts – Week in Pharma News

February 21, 2026

OhioHealth Sued by DOJ for Alleged Anti-Competitive Practices

February 21, 2026

Cancer Immunotherapy Study Faces Data Integrity Concerns | STAT News

February 20, 2026

Pharma & Biotech Moves: CDR-Life Names New CMO | STAT News

February 20, 2026

Grail Cancer Blood Test Fails Key NHS Trial, Shares Plummet

February 20, 2026

Texas Sues Sanofi Over Alleged Doctor Kickback Scheme

February 19, 2026

Grail Cancer Blood Test Fails Key NHS Trial | STAT News

February 18, 2026

AI in Cancer Treatment: Helping Oncologists Personalize Care

February 18, 2026

RFK Jr.’s Health Team Divided on Pharma & Vaccine Policy at PhRMA Forum

February 17, 2026

Ocular Therapeutix’s Axpaxli Shows Promise in Macular Degeneration Trial | STAT News

February 17, 2026

Lilly’s Weight-Loss Drug Stockpile & 340B Program Scrutiny | Pharmalot Roundup

February 16, 2026

Dana-Farber Hospital Split: Staff Feel the Strain of Partnership Breakup

February 16, 2026

Medicare Advantage Enrollment Growth Slows: 2026 Data

February 16, 2026

RFK Jr. to Tackle Ultra-Processed Foods Following FDA Petition